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Abstract 
The reaction of indole derivatives with cyanoacetic acid followed by treatment with DMFDMA 
gave the intermediate indolyl enaminonitriles (3). Further reaction with aminoguanidine yielded 
5´-cyanomeridianin analogues (4). The same intermediate reacted with p-
methoxyphenylhydrazine to give the pyrazolyl derivative (8). 
Treatment of (2E)-3-dimethylamino-2-(1H-indol-3-yl)-propenoate (3a) with hydroxylamine 
hydrochloride in basic medium afforded (5-amino-isoxazol-4-yl)-(1H-indol-3-yl)-methanone (5)  
and the acrylic acid derivative (6) after a short or a long heating, respectively. Unequivocal 
structural elucidation of the latter compound was achieved from single-crystal X-ray diffraction 
studies. 
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Introduction 
  
Enaminonitriles are versatile reagents which have been efficiently utilized for the synthesis of 
heteroaromatics.1 Meridianin alkaloids, isolated from the south atlantic tunicate Aplidium 
meridianum,
2
 are indole derivatives substituted at the C-3 position by a 2-aminopyrimidine ring. 
Since abnormal protein phosphorylation is related to many human diseases interest on the 
search for inhibitors of kinases has increased. A vast number of inhibitors of CDKs have been 
discovered, however, only very few GSK-3 inhibitors have been described.  
Meridianins 
2-4
 (Fig. 1) were described as potent kinase inhibitors,
4
  inhibiting CDKs, GSK-3, 
PKA and other protein kinases in the low micromolar range. Some derivatives displayed also 
antitumor activity.
5 
There are three reported approaches for the synthesis of meridianins from indole derivatives 
based on a Suzuki cross-coupling with indole-3-boronic acid derivatives.
6
 A Bredereck synthesis 
was also described from -enaminones, which were, in turn, obtained from 3-acetylindole 
derivatives.
5,7,8
 More recently, meridianins were also obtained from trimethylsilylynone indole 
derivatives.
9
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Figure 1. General representation of meridianin alkaloids. 
 
 
Results and discussion 
 
Following our interest in the chemistry of -enaminonitriles,10-13 in this manuscript we describe 
our most recent results that explore the potential of 3(2E)-3-dimethylamino-2-(1H-indol-3-yl)-
propenoate in the synthesis of 5´-cyanomeridianin C, G and 3-heteroarylindoles. Commercially 
available indole and indole-3-carboxaldehyde were employed as the starting materials giving 
access to the meridianin analogs 4a-c in a straightforward three-step synthesis following the 
Bredereck approach
7
 (Scheme 1), and to 14 from one-pot synthesis as shown in Scheme 3.  
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Scheme 1 
 
Recently, a facile procedure for the cyanoacetylation of indoles leading to compounds 2a-c 
has been reported.
14
 This one-step approach, applying cyanoacetic acid in acetic anhydride for 
the inclusion of the cyanoacetyl functionality, provides an easy access to cyanoacetylated indoles 
 3 
2a-c. The Bredereck protocol
 7
 was used for the formation of the 2-aminopyrimidine ring. When 
compounds 2a-c were treated with dimethylformamide dimethylacetal (DMFDMA),
15
 without 
solvent at room temperature, the corresponding enaminonitriles 3a-c were obtained in yields 
ranging from 78 to 88%.  
Direct conversion of 3a-c into 5´-cyano meridianin C and meridianin G derivatives 4a-c, 
involving the formation of the 2-aminopyrimidine ring, was achieved in 70-78% by treatment 
with guanidine hydrochloride in the presence of anhydrous potassium carbonate (Scheme 1). The 
structure of compounds 4a-c was established on the basis of elemental analysis, IR, mass, 
1
H and 
13
C NMR spectral data studies (cf. Experimental Section). 
Heating compound 3a for 7 hours, with hydroxylamine hydrochloride in the presence of 
base, did not produce the isoxazole 5, but led instead to the formation of the indole derivative 6. 
The alternative structure 5 was excluded based on FT-IR and NMR data. The 
1
H NMR 
spectrum of 6 showed two signals that are D2O exchangeable at 7.90 and 12.20 and a singlet for 
H-2 at 8.48 ppm, while 
13
C NMR showed a carbonyl signal at 181.55 ppm (C-3). Unequivocal 
structural elucidation was achieved from single-crystal X-ray diffraction studies. Compound 6 
crystallises in the centrosymmetric monoclinic C2/c space group, with the asymmetric unit being 
composed of a whole molecular unit (Figure 2) with typical geometrical features for the bond 
lengths and angles (see caption of Figure 2).  
 
Figure 2. Schematic representation of the molecular unit of compound 6. Non-hydrogen atoms 
are represented as thermal ellipsoids (drawn at the 50% probability level) and hydrogen atoms as 
small spheres with arbitrary radii. The atomic labelling scheme is also provided for all non-
hydrogen atoms. Selected bond lengths (in Å): O1–C1 1.262(2); O2–C1 1.337(3); O3–C4 
1.316(2); N1–C3 1.140(2); N2–C5 1.349(2); N2–C8 1.373(2); C1–C2 1.459(2); C2–C4 1.392(3); 
C2–C3 1.417(2); C4–C6 1.442(2); C5–C6 1.387(2); C6–C7 1.446(2); C7–C12 1.406(2); C7–C8 
1.413(2); C8–C9 1.392(3); C9–C10 1.371(3); C10–C11 1.411(3); C11–C12 1.364(3).  Selected 
bond angles (in degrees): C5–N2–C8 109.70(15); O1–C1–O2 120.18(16); O1–C1–C2 
120.15(17); O2–C1–C2 119.66(16); C4–C2–C3 122.47(15); C4–C2–C1 120.52(15); C3–C2–C1 
116.99(16); N1–C3–C2 176.64(19); O3–C4–C2 119.06(16); O3–C4–C6 113.99(16); C2–C4–C6 
126.95(15); N2–C5–C6 110.16(17); C5–C6–C4 128.31(17); C5–C6–C7 105.91(15); C4–C6–C7 
125.78(15); C12–C7–C8 118.12(17); C12–C7–C6 135.45(16); C8–C7–C6 106.43(15); N2–C8–
C9 129.18(17); N2–C8–C7 107.79(16); C9–C8–C7 123.03(17); C10–C9–C8 117.23(18); C9–
C10–C11 120.8(2); C12–C11–C10 121.9(2); C11–C12–C7 118.86(18). 
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When the reaction proceeded under mild heating conditions, for 30 minutes at 60ºC, the 
product isolated (26%) was the oxazole derivative 5. The singlet due to H-3 may be seen at 8.97 
and the NH2 signal is located at 8.18 ppm and readily exchanges with D2O. It is assumed that 5 
may be formed initially and with prolonged heating, in basic medium, yields 6. Removal of the 
proton 3 from 5, which is known to happen in basic medium, would open the isoxazole ring to an 
amide whose hydrolysis would give the corresponding carboxylic acid derivative (6). Ring 
opening always occurs in the same fashion leading to the stereoisomer E depicted in Figure 2. 
This configuration has important consequences in the crystal packing as it permits the 
existence of a vast network composed of strong and highly directional hydrogen bonding 
interactions (Figure 3a): (i) the carboxylic acid groups of two neighbouring units are engaged in 
a typical R
2
2(8) graph set motif
 16
 [O2–H2···O1i: dD···A of 2.933(2) Å with <(DAH) of ca. 165º; 
symmetry code (i) –x, 2-y, -z], which are reinforced by (ii) two very strong S11(6) intramolecular 
motifs [O3–H3···O1: dD···A of 2.470(2) Å with <(DAH) of ca. 151º]. The two aforementioned 
graph set motifs promote the existence of molecular dimers within the structure (Figure 3a) 
which are, in turn, interconnected by way of two N2–H2A···N1ii interactions [dD···A of 2.932(2) 
Å with <(DAH) of ca. 164º; symmetry code (i) ½–x, 2.5-y, 1-z] involving the heterocyclic NH 
moiety and the pendant C≡N moiety. These interactions promote the existence of a third graph 
set motif, R
2
2(16), which is in the genesis of the one-dimensional zigzag supramolecular tape 
depicted in Figure 3a. Individual tapes close pack in a typical alternate ABAB··· fashion along 
the [100] direction of the unit cell mediated by the need to effectively fill the available space 
(Figure 3b). 
 
Figure 3. (a) Schematic representation of the one-dimensional zigzag supramolecular tape 
assembled by adjacent molecules of compound 6 engaged in strong and highly directional 
(N,O)–H···(N,O) hydrogen bonding interactions (dashed green lines – see main text for 
 5 
geometrical details on the represented interactions).  (b) Close packing of adjacent 
supramolecular tapes (represented in different colour) along the [100] direction of the unit cell 
depicting the actual crystal structure of compound 6. 
 
As anticipated, the treatment of compound 3a with p-methoxyphenylhydrazine, in refluxing 
ethanol, in a basic medium, afforded as  single product  only pyrazole 7 (Scheme 1). The 
structure of the pyrazole 9 was excluded due to the absence of the typical signals of cyano 
groups in both the FT-IR and 
13
C NMR spectra. The 
1
H NMR of compound 7 showed all the 
expected signals which was not sufficient to differentiate between structures 7 and 8. For this 
reason, we collected the HMQC and HMBC NMR spectra and performed an unambiguous 
assignment in the 
1
H and 
13
C NMR spectra (see experimental section). In the HMBC spectrum, 
no correlation peak between the pyrazole H-3 at 8.13 ppm and carbon signals at 130.67 (C-1´´) 
was observed. This occurrence is characteristic only for structure 7 but not for 8.
17 
 
Compound 3a reacted with malononitrile in the presence of piperidine as a catalyst to give 10 
in 75% yield. The structure of compound 10 was readily established from 
1
H NMR data, which 
revealed all the expected protons of the indole moiety alongside with a singlet at 8.59 ppm for 
the H-4 of the pyridinone ring and a NH broad signal at 13.10 ppm. Two signals due to CN 
groups were found in the 
13
C NMR spectrum at 115.44 and 116.96 ppm. The formation of the 
pyridine-3,5-dicarbonitrile 10 from the reaction of 3a with malononitrile is assumed to take place 
through the sequence depicted in Scheme 2. 
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Compound 3a reacted with malononitrile in the presence of piperidine as a catalyst to give 10 
in 75% yield. The structure of compound 10 was readily established from 
1
H NMR data, which 
revealed all the expected protons of the indole moiety alongside with a singlet at 8.59 ppm for 
the H-4 of the pyridinone ring and a NH broad signal at 13.10 ppm. Two signals due to CN 
groups were found in the 
13
C NMR spectrum at 115.44 and 116.96 ppm. The formation of the 
 6 
pyridine-3,5-dicarbonitrile 10 from the reaction of 3a with malononitrile is assumed to take place 
through the sequence depicted in Scheme 1. 
The reactivity of the methylene group in compound 2 was exploited by reacting this 
compound with trichloroacetonitrile in ethanol in the presence of sodium acetate to obtain the 
new enamine 11 (Scheme 1). The structure of compound 11 was established by 
1
H NMR data 
which revealed the absence of a signal for the methylene group and the emergence of another at 
11.98 ppm corresponding to two protons of the amino group. 
Recently Stanovnik et al. reported the synthesis of condensed indolylpyrimidones as 
meridianin analogs
18
 and polycyclic meridianin analogs with the uracil structural unit.
19
 
Treatment of ethyl 2-cyano-3-(1H-indol-3-yl)acrylate (13) with guanidine hydrochloride in the 
presence of anhydrous potassium carbonate in ethanol at reflux temperature affords the 
corresponding 2-amino-6-(1H-indol-3-yl)-4-oxo-1,4-dihydropyrimidine-5-carbonitrile (14) 
(Scheme 3).  
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Conclusion 
 
Two novel indolyl enaminonitriles (3b and 3c) were prepared and reacted with guanidine 
hydrochloride yielding two new meridianine derivatives (4b and 4c).  
The reactivity of the enaminonitrile 3a was tested with p-methoxyphenylhydrazine and 
malononitrile giving a pyrazole derivative 7 and a pyridone derivative 10, respectively. 
The reaction of 3a with hydroxylamine hydrochloride in basic medium produced, as 
expected, the oxazole derivative 5. When the heating period was extended a different product, 
whose structure, 6, was elucidated from single-crystal X-ray diffraction. 
 
 
Experimental Section  
 
General. Melting points were determined on a Gallenkamp melting point apparatus and are 
uncorrected. FT-IR spectra were registered on a Perkin Elmer FT-IR 1600 using Nujol emulsions 
between NaCl plates. 
1
H NMR (300 MHz) and 
13
C NMR (75.4 MHz) spectra were recorded on a 
 7 
Varian Unity Plus Spectrometer at 298 K or on a Bruker Avance III 400 spectrometer (400 MHz 
for 
1
H and 100.6 MHz for 
13
C). Chemical shifts are reported in ppm relative to solvent peak or 
TMS; coupling constants (J) are given in Hz. Double resonance, HMQC (heteronuclear multiple 
quantum coherence) and HMBC (heteronuclear multiple bond correlation) experiments were 
carried out for complete assignment of 
1
H and 
13
C signals in the NMR spectra. ESI mass 
spectrum was obtained on a LC-MS Finnigan LXQ spectrometer. High-resolution mass spectra 
were obtained on a Bruker FTMS APEXIII (ESI-TOF). Elemental analyses were obtained on a 
Leco CHNS-932 instrument.  
 
General procedure for the preparation of compounds 2a-c 
To a solution of cyanoacetic acid (5.0 g, 50 mmol) in Ac2O (50 mL) at 50 °C, indole (5.85 g, 50 
mmol) was added. The resulting solution was heated at 85 °C for 5 min. During that period 3-
cyanoacetylindole started to crystallize. The mixture was allowed to cool and the solid was 
collected, washed with MeOH, and dried. The same procedure was applied with 2-methylindole 
to give 2b and with 5-bromoindole to produce 2c. Compounds 2a, b were found to be identical 
to those described in the literature.
14
   
3-(5-Bromo-1H-indol-3-yl)-3-oxopropanenitrile (2c). Pale yellow solid, Yield 85%, mp 296-
298
o
C, FT-IR (Nujol; in cm
-1
):  = 3205 (NH), 2252 (CN), 1634 (CO); 1H NMR (DMSO-d6):  
= 4.50 (s, 2H, CH2), 7.38 (dd, 1H, J = 8.7, 1.8 Hz, H-6), 7.49 (d, 1H, J = 9.0, Hz, H-7), 8.24 (d, 
1H, J = 2.1 Hz, H-4), 8.41 (s, 1H, H-2), 12.35 (bs, 1H, NH). ). 
13
C NMR (DMSO-d6):  = 29.48 
(CH2), 113.87 (C-3), 114.57 (C-7), 115.07 (C-Br), 116.21 (CN), 123.11 (C-2), 125.94 (C-6), 
126.88 (C-3a), 135.38 (C-7a), 136.55 (C-4), 183.10 (CO). Anal. Calcd. (in %) for C11H7BrN2O 
(263.09): C, 50.22; H, 2.68; N, 10.65. Found: C, 50.10; H, 2.78; N, 10.65. 
 
General procedure to prepare compounds 3a-c 
A mixture of 2a-c (10 mmol) and DMFDMA (11 mmol) was stirred for 5 min. at room 
temperature, and the yellow solid that formed was filtered off and crystallized from EtOH to 
afford 3a-c in 78-88% yield. Compound 3a was found to be identical to that previously described 
in the literature.
5 
3-(Dimethylamino)-2-(1H-indole-3-carbonyl)acrylonitrile (3a). Yellow crystals, yield 78%, 
mp 170-171ºC (lit
5
. mp 160-163
o
C);  = 3.26 (s, 3H, CH3), 3.35 (s, 3H, CH3), 7.13 (td, 1H, J = 
1.2, 6.9 Hz, H-5), 7.18 (td, 1H, J = 6.9 Hz, H-6), 7.46 (dd, 1H, J = 7.8, 2.1 Hz, H-7), 7.99 (s, 1H, 
=CH), 8.13 (dd, 1H, J = 7.5, 2.1 Hz, H-4), 8.27 (d, 1H, J = 3 Hz, H-2,), 11.75 (s, 1H, NH).
 13
C 
NMR (DMSO-d6):  = 38.51 (CH3), 47.39 (CH3), 77.62 (C-CN), 111.70 (C-7), 114.70 (C-3), 
121.12 (C-5), 121.75 (C-4 or CN), 121.78 (C-4 or CN), 122.49 (C-6), 126.77 (C-3a), 131.14 (C-
2), 135.83 (C-7a), 158.67 (=CH), 181.74 (CO). 
3-(Dimethylamino)-2-(2-methyl-1H-indole-3-carbonyl)acrylonitrile (3b). Yellow crystals, 
yield 85%, mp 192-193
o
C, FT-IR (Nujol; in cm
-1
):  = 3274 (NH), 2225 (CN), 1689 (CO); 1H 
NMR (DMSO-d6):  = 2.48 (s, 3H, CH3), 3.19 (s, 3H, N-CH3), 3.35 (s, 3H, N-CH3), 7.00-7.11 
(m, 2H, H-5, 6), 7.32 (dd, 1H, J = 6.9, 2.1 Hz, H-7), 7.56 (dd, 1H, J = 6.9, 2.1 Hz, H-4), 7.74 (s, 
 8 
1H, =CH), 11.54 (s, 1H, NH).
 13
C NMR (DMSO-d6):  = 13.51 (CH3), 38.44 and 47.09 (2 x N-
CH3), 81.38 (C-CN), 110.88 (C-7), 112.90 (C-2), 119.68 (C-4), 120.03 (CN and C-5 or C6), 
121.19 (C-5 or C-6), 126.91 (C-3a), 134.77 (C-7a), 139.69 (C-3), 158.53 (=CH), 185.49 (CO). 
Anal. Calcd. (in %) for C15H15N3O (253.30); C, 71.13; H, 5.97; N, 16.59. Found: C, 70.93; H, 
6.00; N, 16.66. 
2-(5-Bromo-1H-indole-3-carbonyl)-3-(dimethylamino)acrylonitrile (3c). Yellow crystals, 
Yield 88%, mp 252-254
o
C, FT-IR (Nujol; in cm
-1
):  = 3285 (NH), 2227 (CN), 1664 (CO); 1H 
NMR (DMSO-d6):  = 3.27 (s, 3H, CH3), 3.31 (s, 3H, CH3), 7.30 (dd, 1H, J = 8.7, 1.8 Hz, H-6), 
7.45 (d, 1H, J = 9.0 Hz, H-7), 7.99 (s, 1H, =CH), 8.28 (d, 1H, J = 1.8 Hz, H-4), 8.32 (s, 1H, H-
2), 11.92 (bs, 1H, NH). ). 
13
C NMR (DMSO-d6):  = 47.49 and 38.57 (2 x CH3), 77.36 (C-CN ), 
113.94 (C-3 or C-5), 114.02 (C-5 or C-3), 114.22 (C-7), 121.64 (CN), 123.95 (C-4), 125.06 (C-
6), 128.59 (C-3a), 132.33 (C-2), 134.57 (C-7a), 158.75 (C-2), 181.42 (CO). Anal. Calcd. (in %) 
for C14H12BrN3O (318.17): C, 52.85; H, 3.80; N, 13.21. Found: C, 52.86; H, 3.98; N, 13.21. 
 
General procedure to prepare meridianin derivatives 4a-c 
A mixture of enaminonitrile 3a-c (10 mmol), guanidine hydrochloride (12.0 mmol), anhydrous 
K2CO3 (2.0 g, 15.0 mmol), and absolute ethanol (20 mL) was heated at reflux for 7 h. After 
cooling, the mixture was poured into ice-water and the solid formed was filtered off to afford 5´-
cyano-meridianin derivatives 4a-c as yellow solids. Recrystallization from EtOH led to overall 
yields of 70-78%. Spectral data for compound 4a are in good agreement with those reported in 
the literature.
5
 
2-Amino-4-(1H-indol-3-yl)pyrimidine-5-carbonitrile (4a). Off white solid powder (70%), mp 
257-258ºC (lit.
 5 
mp 258-259
o
C). 
1
H NMR (DMSO-d6):  = 7.12-7.27 (m, 2H, H-5´, 6´), 7.50 (d, 
1H, J = 7.5 Hz, H-7´), 7.54 and 7.64 (2 bs, 2H, NH2),), 8.47 (s, 1H, H-6), 8.57 (s, 1H, H-2´), 8.65 
(d, 1H, J= 7.2 Hz, H-4´), 11.95 (bs, 1H, NH). 
13
C NMR (DMSO-d6):  = 89.23 (C-5), 111.56 (C-
3´), 112.04 (C-7´), 119.82 (CN), 121.09 (C-5´), 122.80 (C-6’), 123.27 (C-4´), 125.73 (C-3´a), 
130.04 (C-2’), 136.36 (C-7´a), 163.14 (C-4 or C-2), 163.17 (C-2 or C-4), 165.35 (C-6). 
2-Amino-4-(2-methyl-1H-indol-3-yl)pyrimidine-5-carbonitrile (4b). Yellow powder (74%), 
mp 280-282
o
C, FT-IR (Nujol; in cm
-1
):  = 3295 (NH), 3150 (NH2), 2215 (CN); 
1
H NMR 
(DMSO-d6):  = 2.51 (s, 3H, CH3), 7.02-7.14 (m, 2H, H-5´, 6´), 7.34-7.36 (m, 1H, H-7´), 7.59-
7.61 (m, 1H, H-4´), 7.64 (s, 2H, NH2), 8.65 (s, 1H, H-6), 11.64 (s, 1H, NH).
 13
C NMR (DMSO-
d6):  = 13.82 (CH3), 94.40 (C-5), 109.72 (C-3´), 110.94 (C-7´), 118.40 (CN), 119.51 (C-4´), 
119.78 (C-5´), 121.47 (C-6´), 126.35 (C-3´a), 135.15 (C-7´a), 137.95 (C-2´), 163.17 (C-4 or C-
2), 163.28 (C-2 or C-4), 165.37 (C-6). Anal. Calcd. (in %) for C14H11N5 (249.27): C, 67.46; H, 
4.45; N, 28.10. Found: C, 67.38; H, 4.52; N, 28.15. 
2-Amino-4-(5-bromo-1H-indol-3-yl)pyrimidine-5-carbonitrile (4c). Yellow crystals (78%), 
mp 325-327
o
C, FT-IR (Nujol; in cm
-1
):  = 3428 (NH), 3290, 3148 (NH2), 2211 (CN); 
1
H NMR 
(DMSO-d6):  = 7.34-7.36 (m, 1H, H-6´), 7.47-7.49 (m, 1H, H-7´), 7.57, 7.81 (bs, 2H, NH2), 
8.49 (s, 1H, H-2´), 8.57 (s, 1H, H-6), 8.75 (d, 1H, H-4´), 12.10 (bs, 1H, NH). 
13
C NMR (DMSO-
d6):  = 89.31 (C-5), 111.12 (C-3´), 114.06 (CN), 114.15 (C-7´), 119.60 (C-5´), 125.01 (C-4´), 
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125.51 (C-6´), 127.30 (C-3´a), 131.18 (C-2´), 135.12 (C-7´a), 162.74 (C-4 or C-2), 163.11 (C-2 
or C-4), 163.41 (C-6). Anal. Calcd. (in %) for C13H8BrN5 (314.14): C, 49.70; H, 2.57; N, 22.29. 
Found: C, 49.35; H, 2.68; N, 22.10. 
(5-Amino-isoxazol-4-yl)-(1H-indol-3-yl)-methanone (5). A mixture of enaminonitrile 3a 
(100.5 mg, 0.42 mmol) and anhydrous K2CO3 (84 mg, 0.61 mmol) in absolute ethanol (20 mL) 
was stirred for 10 min. at room temperature. Hydroxylamine hydrochloride (0.5 mmol) was 
added and the mixture was warmed at 60º for 30 min, cooled, poured into ice-water, and 
extracted with diethyl ether (3x50 mL). The combined extracts were dried (MgSO4) and the 
solvent was evaporated to give compound 5 as an off-white solid (25 mg, 29%) mp 217.0-
219.5ºC; 
1
H NMR (DMSO-d6): 7.10-7.24 (m, 2H, H-5´and 6´), 7.46 (d, J=7.0 Hz, 1H, H-7´), 
8.16-8.20 (s, 2H, NH2, exchangeable with D2O), 8.24 (d, 1H, J = 7.0 Hz, H-4´), 8.31(1H, d, 
J=3Hz, H-2’), 8.97 (1H, s, H-3), 11.95 (bs, 1H, NH, exchangeable with D2O). 
13
C NMR 
(DMSO-d6):  = 94.30 (C-4), 115.38 (C-3’), 111.99 (C-7´), 121.32 (C-5´), 121.54 (C-4´), 122.70 
(C-6´), 126.28 (C-3´a), 131.40 (C-2´), 136.26 (C-7´a), 149.82 (C-3), 171.49 (C-5), 180.89 (CO). 
ESI-TOF, C12H10N3O2 (M
+
+1) Calc: 228.07675; Found: 228.07675. 
 
General procedure to prepare compounds 6 and 7. 
A mixture of enaminonitrile 3a (10 mmol), hydroxylamine hydrochloride (6) or p-
methoxyphenyl hydrazine hydrochloride (7) (12.0 mmol), anhydrous K2CO3 (2.0 g, 15.0 mmol), 
and absolute ethanol (20 mL) was heated at reflux for 7 h. After cooling, the mixture was poured 
into ice-water and the resulting solid was filtered off and recrystallized from EtOH. 
2-Cyano-3-hydroxy-3-(1H-indol-3-yl)-acrylic acid (6). Brown crystals (81%), mp 235-237
o
C, 
FT-IR (Nujol):  = 3399, 3256 (NH), 2208 (CN), 1641 (CO) cm-1; 1H NMR (DMSO-d6):  = 
7.19 (dt, 1H, H-5´), 7.24 (dt, 1H, J= 7.2 and 1.2 Hz, H-6´), 7.53 (d, 1H, J = 7.5Hz, H-7´), 7.60-
8.40 (br s, 1H, OH, D2O exchangeable), 8.10 (d, 1H, J = 7.5 Hz, H-4´), 8.48 (d, 1H, J = 3.2 Hz, 
H-2´), 12.20 (s, 1H, NH, D2O exchangeable). 
13
C NMR (DMSO-d6):  = 69.53 (C-2), 109.30 (C-
3´), 112.55 (C-7´), 119.19 (CN), 121.91 (C-5´) 121.96 (C-4´), 123.10 (C-6´), 125.59 (C-3´a), 
132.28 (C-2´), 135.98 (C-7´a), 173.96 (C-1), 181.55 (C-3). ESI
-
-MS: 208.17 ([M-1]
+
). Anal. 
Calcd. (in %) for C12H7N3O (209.20): C, 68.89; H, 3.37; N, 20.09. Found: C, 68.45; H, 3.27; N, 
20.39. 
(5-Amino-1-(4-methoxyphenyl)-1H-pyrazol-4-yl)(1H-indol-3-yl)methanone (7). Brown 
crystals (81%), mp 230-232
o
C, FT-IR (Nujol):  = 3278 (NH), 1650 (CO), cm-1; 1H NMR 
(DMSO-d6):  = 3.82 (s, 3H, OCH3), 6.81 (s, 2H, NH2), 7.10 (d, 2H, J = 9.0 Hz, (H-3´´,5´´), 
7.14-7.22 (m, 2H, H-5´, 6´), 7.45-7.47 (m, 1H, H-7´), 7.49 (d, 2H, J = 9.0 Hz, (H-2´´,6´´), 8.13 
(s, 1H, H-3), 8.23-8.25 (m, 1H, H-4´), 8.29 (d, 1H, J = 2.7 Hz, H-2´), 11.86 (s, 1H, NH). 
13
C 
NMR (DMSO-d6):  = 55.47 (OCH3), 104.09 (C-4), 111.88 (C-7´), 114.58 (C-3´´,5´´), 115.97 
(C-3´), 121.05 (C-5´), 121.56 (C-4´), 122.51 (C-6´), 125.52 (C-2´´,6´´), 126.40 (C-3´a), 130.67 
(C-1´´), 131.03 (C-2´), 136.22 (C-7´a), 139.96 (C-3), 150.40 (C-5), 158.47 (C-4´´), 182.94 (CO). 
ESI
+
-MS: 333.33 ([M+1]
+
). Anal. Calcd. (in %) for C19H16N4O2 (332.36): C, 68.66; H, 4.85; N, 
16.86. Found: C, 68.49; H, 5.00; N, 16.86. 
 10 
6-(1H-Indol-3-yl)-2-oxo-1,2-dihydropyridine-3,5-dicarbonitrile (10). To a mixture of 
enaminonitrile 3a (10 mmol) and malononitrile (0.66 g; 10 mmol) in ethanol (15 mL) piperidine 
(0.2 mL) was added. The reaction mixture was refluxed for 3 h and was then left to cool to room 
temperature. The precipitated product was collected by filtration and crystallized from ethanol to 
afford 10 as brown crystals in 75 % yield. mp 198-200
o
C, FT-IR (Nujol):  = 3266 (NH), 22211 
(CN), 1634 (CO), cm
-1
; 
1
H NMR (DMSO-d6):  = 7.18-7.29 (m, 2H, H-5´, 6´), 7.52-7.55 (m, 1H, 
H-7´), 7.72 (d, 1H, J = 7.2Hz, H-4´), 8.14 (d, 1H, J = 3.0 Hz, H-2´), 8.59 (s, 1H, H-4), 12.24 (s, 
1H, NH indole), 13.10 (bs, 1H, NH). 
13
C NMR (DMSO-d6):  = 88.71 (C-5), 99.55 (C-3), 106.14 
(C-3´), 122.58 (C-7´), 115.44 (CN), 116.96 (CN), 120.46 (C-4´), 121.0 (C-5´), 122.97 (C-6´), 
124.16 (C-3´a), 131.11 (C-2´), 136.31 (C-7´a), 150.53 (C-4), 155.05 (C-6), 160.17 (CO). ESI
-
-
MS: 259.10 ([M-1]
+
). Anal. Calcd. (in %) for C15H8N4O (260.25): C, 69.23; H, 3.10; N, 21.53. 
Found: C, 69.09; H, 3.41; N, 21.68. 
3-Amino-4,4,4-trichloro-2-(1H-indole-3-carbonyl)but-2-enenitrile (11). To a solution of 2a (10 
mmol) in ethanol (25 ml) and sodium acetate (4.1 g, 50 mmol), trichloroacetonitrile (4.33 g, 30 
mmol) was added. The reaction mixture was stirred for 48h and then poured into water, and the 
solid product was filtered off and crystallized from dimethylformamide to give 9 as a brown 
powder (74%), mp 212-214
o
C, FT-IR (Nujol):  = 3279 (NH), 2215 (CN), 1620 (CO), cm-1; 1H 
NMR (DMSO-d6):  = 7.18-7.24 (m, 2H, H-5´, 6´), 7.48-7.51 (m, 1H, H-7´), 8.16-8.18 (m, 1H, 
H-4´), 8.47 (d, 1H, J = 3.2 Hz, H-2´), 9.42 (bs, 1H, NH), 11.98 (s, 2H, NH2). 
13
C NMR (DMSO-
d6):  = 76.10 (C-2) 91.61 (C-4, CCl3), 112.22 (C-7´), 114.52 (C-3´), 119.80 (CN), 121.76 (C-
5´), 121.78 (C-4´), 122.92 (C-6´), 126.54 (C-3´a), 132.28 (C-2´), 135.77 (C-7´a), 167.41 (C-3), 
185.45 (CO). ESI
-
-MS: 326.17 (
35
Cl, [M-1]
+
), 328.08 (
35
Cl (2), 
37
Cl, [M-1]
+
), 330.00 (
35
Cl, 
37
Cl(2) [M-1]
+
). Anal. Calcd. (in %) for C13H8Cl3N3O (328.58): C, 47.52; H, 2.45; N, 12.79. 
Found: C, 47.26; H, 2.85; N, 12.81. 
Ethyl 2-cyano-3-(1H-indol-3-yl)acrylate (13). To a solution of 3-formylindole (10 mmol) in 
ethanol (25 ml) and ethylcyanoacetate (10 mmol), and piperidine (0.2 mL) was added. The 
reaction mixture was refluxed for 2 h and then left to cool to room temperature. The solid that 
precipitated was filtered off and recrystallized from ethanol to give 13 as yellow crystals in 92% 
yield. mp 170-171
o
C, FT-IR (Nujol):  = 3278 (NH), 2224 (CN), 1680 (CO), cm-1; 1H NMR 
(CDCl3):  = 1.41 (t, 3H, J = 7.2 Hz, CH3), 4.38 (q, 2H, J = 7.2 Hz, CH2), 7.32-7.36 (m, 2H, H-
5´,6´), 7.48-7.51 (m, 1H, H-7´), 7.84-7.86 (m, 1H, H-4´), 8.64 (s, 1H, =CH), 8.67 (d, 1H, J = 3.3 
Hz, H-2´), 9.24 (bs, 1H, NH). 
13
C NMR (CDCl3):  = 14.30 (CH3), 62.04 (CH2), 94.93 (C-2), 
111.23 (C-3´), 112.20 (C-7´), 118.13 (CN), 118.33 (C-4´), 122.65 (C-5´), 124.23 (C-6´), 127.39 
(C-3´a), 130.68 (C-2´), 135.60 (C-7´a), 146.55 (C-3´), 163.76 (C-1). Anal. Calcd. (in %) for 
C14H12N2O2 (240.26): C, 69.99; H, 5.03; N, 11.66. Found: C, 69.97; H, 5.16; N, 11.86. 
2-Amino-6-(1H-indol-3-yl)-4-oxo-1,4-dihydropyrimidine-5-carbonitrile (14). A mixture of 
13 (10 mmol), guanidine hydrochloride (12.0 mmol), anhydrous K2CO3 (2.0 g, 15.0 mmol), and 
absolute ethanol (20 mL) was heated at reflux temperature for 7 h. After cooling, the mixture 
was poured into ice-water and neutralized with acetic acid. A solid product formed which was 
filtered off and recrystallized from EtOH to afford 14 as a yellow solid in 77 % yield. mp 252-
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253
o
C, FT-IR (Nujol):  = 3327 (NH), 2211 (CN), 1659 (CO), cm-1; 1H NMR (DMSO-d6):  = 
7.10-7.22 (m, 4H, H-5´, 6´, NH2), 7.47 (d, 1H, J = 8.4 Hz, H-7´), 8.44 (d, 1H, J = 3.0 Hz, H-2´), 
8.57 (d, 1H, J = 7.5Hz, H-4´), 11.31 (s, 1H, NH indole), 11.92 (s, 1H, NH). 
13
C NMR (DMSO-
d6):  = 79.40 (C-5) 111.77 (C-3´), 111.96 (C-7´), 119.28 (CN), 120.88 (C-5´), 122.54 (C-6´), 
123.51 (C-4´), 126.13 (C-3´a), 130.51 (C-2´), 136.25 (C-7´a), 155.98 (C-2), 162.21 (CO), 166.67 
(C-6). ESI
-
-MS: 250.08 ([M-1]
+
). Anal. Calcd. (in %) for C13H9N5O (251.24): C, 62.15; H, 3.61; 
N, 27.87. Found: C, 62.40; H, 3.26; N, 27.77. 
 
Single-crystal X-ray Diffraction 
A single-crystal of compound 6 was manually harvested from the crystallization vial and 
mounted on a Hampton Research CryoLoop using FOMBLIN Y perfluoropolyether vacuum oil 
(LVAC 25/6) purchased from Aldrich
20
 with the help of a Stemi 2000 stereomicroscope 
equipped with Carl Zeiss lenses. Data were collected at 150(2) K on a Bruker X8 Kappa APEX 
II charge-coupled device (CCD) area-detector diffractometer (Mo K graphite-monochromated 
radiation,  = 0.71073 Å) controlled by the APEX2 software package,21  and equipped with an 
Oxford Cryosystems Series 700 cryostream monitored remotely using the software interface 
Cryopad.
22
 Images were processed using the software package SAINT+,
 23
 and data were 
corrected for absorption by the multi-scan semi-empirical method implemented in SADABS.
24
 
The crystal structure was solved by employing the direct methods implemented in SHELXS-97.
 
25,26
 This strategy allowed the immediate location of the vast majority of the atoms.  All the 
remaining non-hydrogen atoms were directly located from difference Fourier maps calculated 
from successive full-matrix least squares refinement cycles on F
2
 using SHELXL-97.
26,27
  All 
non-hydrogen atoms have been successfully refined using anisotropic displacement parameters.  
Hydrogen atoms bound to carbon/nitrogen and oxygen were placed at their idealized 
positions using the HFIX 43 or 147 instructions in SHELXL and included in subsequent 
refinement cycles in riding-motion approximation with isotropic thermal displacements 
parameters (Uiso) fixed at 1.2 or 1.5×Ueq of the carbon/nitrogen or oxygen atom to which they are 
attached, respectively.  The last difference Fourier map synthesis showed the highest peak 
(0.494 eÅ
-3
) and deepest hole (-0.635 eÅ
-3
) located at 0.40 Å and 0.51 Å from O1 and O2, 
respectively. 
Crystal data: C12H8N2O3, M = 228.20, monoclinic, space group C2/c, Z = 8, a = 27.964(6) Å, 
b = 5.3241(11) Å, c = 17.278(4) Å, β = 124.186(19)º, V = 2127.9(8) Å3, (MoK) = 0.105 mm
–1
, 
Dc = 1.425 g cm
–3
, brown prism with crystal size of ca. 0.250.200.20 mm3.  Of a total of 
39590 reflections collected, 2856 were independent (Rint = 0.0308). Final R1 = 0.0602 [I > 2(I)] 
and wR2 = 0.2172 (all data). Data completeness to theta = 29.13°, 99.6%. 
Crystallographic data (excluding structure factors) for compound 6 have been deposited with 
the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC-816317.  
Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, 
Cambridge CB2 2EZ, U.K. Fax: (+44) 1223 336033. E-mail: deposit@ccdc.cam.ac.uk. 
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